STAT3 activation, chemokine receptor expression, and cyclin-cdk function in B-1 cells

被引：0
|
作者：
Rothstein, TL [1 ]
Fischer, GM
Tanguay, DA
Pavlovic, S
Colarusso, TP
Gerstein, RM
Clarke, SH
Chiles, TC
机构：
[1] Boston Univ, Med Ctr, Dept Med, Immunobiol Unit, Boston, MA 02215 USA
[2] Boston Univ, Med Ctr, Dept Microbiol, Boston, MA USA
[3] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA
[4] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA
[5] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA
来源：
B 1 LYMPHOCYTES IN B CELL NEOPLASIA | 2000年 / 252卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：121 / 130
页数：10
相关论文
共 50 条
  • [21] Cutting edge: Differential signaling requirements for activation of assembled cyclin D3-cdk4 complexes in B-1 and B-2 lymphocyte subsets
    Tanguay, DA
    Colarusso, TP
    Doughty, C
    Pavlovic-Ewers, S
    Rothstein, TL
    Chiles, TC
    JOURNAL OF IMMUNOLOGY, 2001, 166 (07): : 4273 - 4277
  • [22] Overexpression of cyclin D1 correlates to the activation of Stat3 during mouse hepatic carcinogenesis
    Miyakoshi, Masaaki
    Yamamoto, Masahiro
    Tanaka, Hiroki
    Hashimoto, Norikazu
    Tamakawa, Susumu
    Yoshie, Masumi
    Tokusashi, Yoshihiko
    Yaginuma, Yuji
    Ogawa, Katsuhiro
    CANCER RESEARCH, 2006, 66 (08)
  • [23] Dual inhibition of STAT1 and STAT3 activation downregulates expression of PD-L1 in human breast cancer cells
    Nair, Varun Sasidharan
    Toor, Salman M.
    Ali, Bassam R.
    Elkord, Eyad
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2018, 22 (06) : 547 - 557
  • [24] CADPE Suppresses Cyclin D1 Expression in Hepatocellular Carcinoma by Blocking IL-6-induced STAT3 Activation
    Won, Cheolhee
    Lee, Chang Seok
    Lee, Jin-Ku
    Kim, Tack-Joong
    Lee, Kwang-Ho
    Yang, Young Mok
    Kim, Yong-Nyun
    Ye, Sang-Kyu
    Chung, Myung-Hee
    ANTICANCER RESEARCH, 2010, 30 (02) : 481 - 488
  • [25] STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors
    Heehyoung Lee
    Jiehui Deng
    Maciej Kujawski
    Chunmei Yang
    Yong Liu
    Andreas Herrmann
    Marcin Kortylewski
    David Horne
    George Somlo
    Stephen Forman
    Richard Jove
    Hua Yu
    Nature Medicine, 2010, 16 : 1421 - 1428
  • [26] STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors
    Lee, Heehyoung
    Deng, Jiehui
    Kujawski, Maciej
    Yang, Chunmei
    Liu, Yong
    Herrmann, Andreas
    Kortylewski, Marcin
    Horne, David
    Somlo, George
    Forman, Stephen
    Jove, Richard
    Yu, Hua
    NATURE MEDICINE, 2010, 16 (12) : 1421 - U105
  • [27] Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation
    Cheng, JG
    Chen, JR
    Hernandez, L
    Alvord, WG
    Stewart, CL
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (15) : 8680 - 8685
  • [28] Cytokine-stimulated GTP cyclohydrolase I expression in endothelial cells requires coordinated activation of nuclear factor-κB and Stat1/Stat3
    Huang, AN
    Zhang, YY
    Chen, K
    Hatakeyama, K
    Keaney, JF
    CIRCULATION RESEARCH, 2005, 96 (02) : 164 - 171
  • [29] Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma
    Campbell, CL
    Jiang, Z
    Savarese, DMF
    Savarese, TM
    AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (01): : 25 - 32
  • [30] Amplified STAT3 signaling alters expression of CD39 in STAT3 gain-of-function (STAT3 GOF) and in healthy donor CD8+ T cells
    Duran, Jose S. Campos
    Sayed, Samir
    Conrey, Peyton E.
    Hay, Ceire A.
    Dalalo, Megan C.
    Schmitt, Erica G.
    Mauracher, Andrea A.
    Romberg, Neil D.
    Holland, Steven M.
    Freeman, Alexandra F.
    Bergerson, Jenna R. E.
    Su, Helen C.
    Leiding, Jennifer W.
    Forbes, Lisa R.
    Cooper, Megan A.
    Vogel, Tiphanie P.
    Henrickson, Sarah E.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
12345